Literature DB >> 10903929

A member of a gene family on Xp22.3, VCX-A, is deleted in patients with X-linked nonspecific mental retardation.

M Fukami1, S Kirsch, S Schiller, A Richter, V Benes, B Franco, K Muroya, E Rao, S Merker, B Niesler, A Ballabio, W Ansorge, T Ogata, G A Rappold.   

Abstract

X-linked nonspecific mental retardation (MRX) has a frequency of 0.15% in the male population and is caused by defects in several different genes on the human X chromosome. Genotype-phenotype correlations in male patients with a partial nullisomy of the X chromosome have suggested that at least one locus involved in MRX is on Xp22.3. Previous deletion mapping has shown that this gene resides between markers DXS1060 and DXS1139, a region encompassing approximately 1.5 Mb of DNA. Analyzing the DNA of 15 males with Xp deletions, we were able to narrow this MRX critical interval to approximately 15 kb of DNA. Only one gene, VCX-A (variably charged, X chromosome mRNA on CRI-S232A), was shown to reside in this interval. Because of a variable number of tandem 30-bp repeats in the VCX-A gene, the size of the predicted protein is 186-226 amino acids. VCX-A belongs to a gene family containing at least four nearly identical paralogues on Xp22.3 (VCX-A, -B, -B1, and -C) and two on Yq11.2 (VCY-D, VCY-E), suggesting that the X and Y copies were created by duplication events. We have found that VCX-A is retained in all patients with normal intelligence and is deleted in all patients with mental retardation. There is no correlation between the presence or absence of VCX-B1, -B, and VCX-C and mental status in our patients. These results suggest that VCX-A is sufficient to maintain normal mental development.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10903929      PMCID: PMC1287516          DOI: 10.1086/303047

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  36 in total

Review 1.  Breakthroughs in molecular and cellular mechanisms underlying X-linked mental retardation.

Authors:  J Chelly
Journal:  Hum Mol Genet       Date:  1999       Impact factor: 6.150

2.  Two families of low-copy-number repeats are interspersed on Xp22.3: implications for the high frequency of deletions in this region.

Authors:  A Ballabio; B Bardoni; S Guioli; E Basler; G Camerino
Journal:  Genomics       Date:  1990-10       Impact factor: 5.736

3.  Molecular studies of deletions at the human steroid sulfatase locus.

Authors:  L J Shapiro; P Yen; D Pomerantz; E Martin; L Rolewic; T Mohandas
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

4.  A ring X chromosome, 46,Y,r(X)(p22.33q28), as a cause of extreme short stature in a male.

Authors:  T Ogata; N Matsuo; N Shimizu
Journal:  Am J Med Genet       Date:  1990-02

Review 5.  X-linked mental retardation.

Authors:  G Turner; J M Opitz
Journal:  Am J Med Genet       Date:  1980

6.  A human sex-chromosomal gene family expressed in male germ cells and encoding variably charged proteins.

Authors:  B T Lahn; D C Page
Journal:  Hum Mol Genet       Date:  2000-01-22       Impact factor: 6.150

7.  Contiguous gene syndromes due to deletions in the distal short arm of the human X chromosome.

Authors:  A Ballabio; B Bardoni; R Carrozzo; G Andria; D Bick; L Campbell; B Hamel; M A Ferguson-Smith; G Gimelli; M Fraccaro
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

8.  Frequent deletions of the human X chromosome distal short arm result from recombination between low copy repetitive elements.

Authors:  P H Yen; X M Li; S P Tsai; C Johnson; T Mohandas; L J Shapiro
Journal:  Cell       Date:  1990-05-18       Impact factor: 41.582

9.  Chondrodysplasia punctata with X;Y translocation.

Authors:  K Agematsu; K Koike; H Morosawa; Y Nakahori; Y Nakagome; T Akabane
Journal:  Hum Genet       Date:  1988-09       Impact factor: 4.132

10.  Partial deletions of a sequence family ("DXS278") and its physical linkage to steroid sulfatase as detected by pulsed-field gel electrophoresis.

Authors:  R E Schnur; R G Knowlton; M A Musarella; M Muenke; R L Nussbaum
Journal:  Genomics       Date:  1990-10       Impact factor: 5.736

View more
  22 in total

1.  Studying Protein Function and the Role of Altered Protein Expression by Antibody Interference and Three-dimensional Reconstructions.

Authors:  Kristin Derlig; Andreas Gießl; Johann Helmut Brandstätter; Ralf Enz; Regina Dahlhaus
Journal:  J Vis Exp       Date:  2016-04-21       Impact factor: 1.355

2.  Copy number gain at Xp22.31 includes complex duplication rearrangements and recurrent triplications.

Authors:  Pengfei Liu; Ayelet Erez; Sandesh C Sreenath Nagamani; Weimin Bi; Claudia M B Carvalho; Alexandra D Simmons; Joanna Wiszniewska; Ping Fang; Patricia A Eng; M Lance Cooper; V Reid Sutton; Elizabeth R Roeder; John B Bodensteiner; Mauricio R Delgado; Siddharth K Prakash; John W Belmont; Pawel Stankiewicz; Jonathan S Berg; Marwan Shinawi; Ankita Patel; Sau Wai Cheung; James R Lupski
Journal:  Hum Mol Genet       Date:  2011-02-25       Impact factor: 6.150

3.  The origin and evolution of human ampliconic gene families and ampliconic structure.

Authors:  Bejon Kumar Bhowmick; Yoko Satta; Naoyuki Takahata
Journal:  Genome Res       Date:  2006-12-21       Impact factor: 9.043

4.  Decreased expression of genes associated with memory and x-linked mental retardation in boys with non-syndromic cryptorchidism and high infertility risk.

Authors:  F Hadziselimovic; N O Hadziselimovic; P Demougin; E J Oakeley
Journal:  Mol Syndromol       Date:  2014-01-29

5.  Mutations in DCPS and EDC3 in autosomal recessive intellectual disability indicate a crucial role for mRNA decapping in neurodevelopment.

Authors:  Iltaf Ahmed; Rebecca Buchert; Mi Zhou; Xinfu Jiao; Kirti Mittal; Taimoor I Sheikh; Ute Scheller; Nasim Vasli; Muhammad Arshad Rafiq; M Qasim Brohi; Anna Mikhailov; Muhammad Ayaz; Attya Bhatti; Heinrich Sticht; Tanveer Nasr; Melissa T Carter; Steffen Uebe; André Reis; Muhammad Ayub; Peter John; Megerditch Kiledjian; John B Vincent; Rami Abou Jamra
Journal:  Hum Mol Genet       Date:  2015-02-20       Impact factor: 6.150

6.  Evolutionary dynamics of duplicated microsatellites shared by sex chromosomes.

Authors:  Patricia Balaresque; Bruno Toupance; Evelyne Heyer; Brigitte Crouau-Roy
Journal:  J Mol Evol       Date:  2003       Impact factor: 2.395

7.  Modulation of neuritogenesis by a protein implicated in X-linked mental retardation.

Authors:  Xinfu Jiao; Hongxin Chen; Jianmin Chen; Karl Herrup; Bonnie L Firestein; Megerditch Kiledjian
Journal:  J Neurosci       Date:  2009-10-07       Impact factor: 6.167

8.  X-linked mental retardation and autism are associated with a mutation in the NLGN4 gene, a member of the neuroligin family.

Authors:  Frédéric Laumonnier; Frédérique Bonnet-Brilhault; Marie Gomot; Romuald Blanc; Albert David; Marie-Pierre Moizard; Martine Raynaud; Nathalie Ronce; Eric Lemonnier; Patrick Calvas; Béatrice Laudier; Jamel Chelly; Jean-Pierre Fryns; Hans-Hilger Ropers; Ben C J Hamel; Christian Andres; Catherine Barthélémy; Claude Moraine; Sylvain Briault
Journal:  Am J Hum Genet       Date:  2004-02-12       Impact factor: 11.025

9.  Microarray based comparative genomic hybridisation (array-CGH) detects submicroscopic chromosomal deletions and duplications in patients with learning disability/mental retardation and dysmorphic features.

Authors:  C Shaw-Smith; R Redon; L Rickman; M Rio; L Willatt; H Fiegler; H Firth; D Sanlaville; R Winter; L Colleaux; M Bobrow; N P Carter
Journal:  J Med Genet       Date:  2004-04       Impact factor: 6.318

10.  A search for novel cancer/testis antigens in lung cancer identifies VCX/Y genes, expanding the repertoire of potential immunotherapeutic targets.

Authors:  Ayumu Taguchi; Allen D Taylor; Jaime Rodriguez; Müge Celiktaş; Hui Liu; Xiaotu Ma; Qing Zhang; Chee-Hong Wong; Alice Chin; Luc Girard; Carmen Behrens; Wan L Lam; Stephen Lam; John D Minna; Ignacio I Wistuba; Adi F Gazdar; Samir M Hanash
Journal:  Cancer Res       Date:  2014-06-26       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.